Skip to main content
. 2012 May 9;176(1):1–13. doi: 10.1093/aje/kwr482

Table 1.

Characteristics of Participants in the Women’s Health Initiative (WHI) Calcium and Vitamin D Trial at the Time of WHI Screening (i.e., Year 0), by Supplementation Group, 1995–2000

Characteristic Supplementation Group Placebo Group P Value
No. %a No. %a
Age, years >0.99
    50–59 6,726 37.0 6,696 37.0
    60–69 8,276 45.5 8,243 45.5
    70–79 3,174 17.5 3,167 17.5
Race/ethnicity 0.45
    White 15,051 82.8 15,104 83.4
    Black 1,680 9.2 1,635 9.0
    Hispanic 785 4.3 717 4.0
    American Indian 77 0.4 72 0.4
    Asian/Pacific Islander 370 2.0 351 1.9
Annual income, dollars 0.68
    <20,000 2,942 16.2 2,876 15.9
    20,000–49,999 8,122 44.7 8,092 44.7
    ≥50,000 6,205 34.1 6,192 34.2
Marital status 0.96
    Never married 725 4.0 712 3.9
    Divorced/separated 2,850 15.7 2,875 15.9
    Widowed 3,004 16.5 3,008 16.6
    Married/living as married 11,522 63.4 11,442 63.2
Regional solar irradiance, Langleys >0.99
    475–500 3,861 21.2 3,852 21.3
    400–430 3,016 16.6 3,012 16.7
    75–380 2,009 11.1 2,009 11.1
    350 3,924 21.6 3,879 21.4
    300–325 5,366 29.5 5,354 29.6
Smoking status 0.50
    Never smoker 9,325 51.3 9,428 52.1
    Past smoker 7,255 39.9 7,133 39.4
    Current smoker 1,405 7.7 1,356 7.5
Alcohol intake, drinks/day 0.63
    0 5,055 27.8 5,100 28.2
    >0–<1 11,065 60.9 10,977 60.6
    ≥1 1,908 10.5 1,900 10.5
Hormone useb 0.24
    Never use 5,810 32.0 5,685 31.4
    Past use 3,007 16.5 2,937 16.2
    Current use 9,359 51.5 9,484 52.4
Body mass indexc 0.17
    <25 4,745 26.1 4,834 26.7
    25–<30 6,476 35.6 6,487 35.8
    ≥30 6,870 37.8 6,692 37.0
Physical activity, MET-hours/week 0.60
    <3.00 5,405 29.7 5,340 29.5
    3.00–9.99 4,642 25.5 4,648 25.7
    10.00–19.99 3,647 20.1 3,569 19.7
    ≥20.00 2,852 15.7 2,891 16.0
Total vitamin D intake, IU/day 0.32
    <100 2,750 15.1 2,653 14.7
    100–<200 4,092 22.5 4,025 22.2
    200–<400 3,373 18.6 3,419 18.9
    400–<600 4,180 23.0 4,293 23.7
    ≥600 3,426 18.8 3,363 18.6
Dietary vitamin D intake, IU/day 0.47
    <100 4,893 26.9 4,747 26.2
    100–<200 7,434 40.9 7,496 41.4
    200–<400 4,651 25.6 4,651 25.7
    ≥400 843 4.6 859 4.7
Supplemental vitamin D intake, IU/day 0.41
    None 9,639 53.0 9,507 52.5
    <400 1,795 9.9 1,780 9.8
    400–<800 6,339 34.9 6,401 35.4
    ≥800 403 2.2 418 2.3
Meeting IOM guidelines for vitamin D intaked 0.99
    No 15,379 84.6 15,430 85.2
    Yes 2,374 13.1 2,391 13.2
Total calcium intake, mg/day 0.44
    <400 1,318 7.3 1,273 7.0
    400–<800 4,790 26.4 4,732 26.1
    800–<1,000 2,514 13.8 2,459 13.6
    1,000–<1,200 2,198 12.1 2,195 12.1
    ≥1,200 7,001 38.5 7,094 39.2
Dietary calcium intake, IU/day 0.52
    <400 2,406 13.2 2,378 13.1
    400–<800 7,629 42.0 7,603 42.0
    800–<1,000 2,906 16.0 2,878 15.9
    1,000–<1,200 1,868 10.3 1,853 10.2
    ≥1,200 3,012 16.6 3,041 16.8
Supplemental calcium intake, IU/day 0.55
    None 8,027 44.2 7,885 43.5
    <400 4,289 23.6 4,295 23.7
    400–<800 3,358 18.5 3,406 18.8
    ≥800 2,502 13.8 2,520 13.9
Total saturated fat intake, g/day 0.79
    <15.1 4,469 24.6 4,415 24.4
    15.1–21.4 4,463 24.6 4,479 24.7
    21.5–29.7 4,505 24.8 4,367 24.1
    ≥29.8 4,384 24.1 4,492 24.8
Use of antidepressant medicationb 0.03
    No 16,992 93.5 16,820 92.9
    Yes 1,184 6.5 1,286 7.1
Burnam depression scale (37) scoreb 0.25
    <0.06 16,401 90.2 16,244 89.7
    ≥0.06 1,708 9.4 1,790 9.9
WHI Hormone Trial assignment 0.74
    Not randomized 10,122 55.7 10,071 55.6
    Active 4,039 22.2 4,078 22.5
    Placebo 4,015 22.1 3,957 21.9
WHI Dietary Modification Trial assignment 0.30
    Not randomized 5,582 30.7 5,490 30.3
    Intervention 4,767 26.2 4,878 26.9
    Comparison 7,827 43.1 7,738 42.7

Abbreviations: IOM, Institute of Medicine; MET, metabolic equivalent task; WHI, Women’s Health Initiative.

a

Percentages may not sum to 100 because of missing data.

b

Measured at year 1.

c

Weight (kg)/height (m)2.

d

The IOM guidelines for vitamin D intake are ≥600 IU/day for women aged 50–70 years and ≥800 IU/day for women aged ≥70 years (42).